One should also remember that AML is a heterogeneous disease (this is true even for AML cell expression of Exportin 1) and that the antileukemic effect of Exportin 1 inhibition will probably depend on the AML cell phenotype and vary between patient subsets. The gene discussed is XPO1; the disease is acute myeloid leukemia.